液体活检在消化道肿瘤诊治中的应用进展
Y Jun - 中华结直肠疾病电子杂志, 2022 - zhjzcjbdzzz.cma-cmc.com.cn
… as circulating tumor cells, circulating tumor DNA, microRNA, and exosomes. In recent years,
tumors of the digestive system, represented by pancreatic … detection of pancreatic cancers[J]. …
tumors of the digestive system, represented by pancreatic … detection of pancreatic cancers[J]. …
[PDF][PDF] 精准医疗大环境下血游离DNA 突变检测对胰腺癌诊治发展的临床意义
秦仁义， 赵炎 - 中国普通外科杂志, 2016 - zpwz.net
… direction of diagnosis and treatment of pancreatic cancer. … Oncogenic KRAS signalling in
pancreatic cancer[J]. Br J … Circulating tumour DNA profiling reveals heterogeneity of EGFR …
pancreatic cancer[J]. Br J … Circulating tumour DNA profiling reveals heterogeneity of EGFR …
Macrophage Proliferation Machinery Drives Immunosuppression and PDAC Progression (巨噬细胞增值机制抑制肿瘤免疫促进胰腺癌发展)
C Zuo - 2022 - openscholarship.wustl.edu
… In conclusion, current treatments for pancreatic cancer are … of the heterogeneity and function
of cancer associated fibroblasts is … Tumor cells recruit the types of immune cells that are …
of cancer associated fibroblasts is … Tumor cells recruit the types of immune cells that are …
RAS 突变型转移性结直肠癌的精准治疗
邹佳运， 杨天瑶， 王颖 - 肿瘤防治研究, 2021 - zlfzyj.com
… cancer (mCRC) is a clinical and molecular heterogeneous … 肿瘤脱氧核糖核酸 (circulating
tumor deoxyribonucleic acid, ctDNA) … Emergence of KRAS mutations and acquired resistance to …
tumor deoxyribonucleic acid, ctDNA) … Emergence of KRAS mutations and acquired resistance to …
[HTML][HTML] KRAS/BRAF 基因与结肠癌糖代谢研究现状
刘亮， 黄劲柏， 邱大胜 - 世界华人消化杂志, 2017 - wjgnet.com
… In this review, we summarize the current findings discussing the underlying mechanisms
between glucose metabolism and KRAS/BRAF gene mutation in colon cancer. …
between glucose metabolism and KRAS/BRAF gene mutation in colon cancer. …
[HTML][HTML] 多发肺结节的基础研究和临床治疗进展
吴雪杰， 陈东来， 朱蓉英， 王一飞， 陈昶… - … of Lung Cancer, 2019 - ncbi.nlm.nih.gov
… -tumoral and intratumoral homogeneity and heterogeneity of the genomics also arouse
attention… 被称为“液体活检”的外周血循环肿瘤DNA（circulating tumor DNA, ctDNA）和外泌体检测，极…
attention… 被称为“液体活检”的外周血循环肿瘤DNA（circulating tumor DNA, ctDNA）和外泌体检测，极…
[PDF][PDF] 肝内胆管癌的分子靶向治疗研究进展
段诣， 胡粟衔， 杨旭鹏， 武志华， 段友容， 孙颖 - 肿瘤, 2022 - tumorsci.org
… effect on this highly heterogeneous disease. Therapeutic … KRAS 基因突变导致的耐 药有关
[17],因此通过建立存在KRAS … 在进展后的循环肿瘤DNA(circulating tumor DNA,ctDNA)检测中…
[17],因此通过建立存在KRAS … 在进展后的循环肿瘤DNA(circulating tumor DNA,ctDNA)检测中…
[PDF][PDF] 癌症液体活检新思路: 数字PCR 检测DNA 甲基化
曹雷， 郭利娟， 郭晓锦， 巩燕， 李菲 - 生物化学与生物物理进展, 2019 - researchgate.net
… (circulating tumor cell, CTC),循环肿瘤DNA (circulating tumor … in the plasma of patients with
pancreatic cancer. Scand J Surg, … of invasion and heterogeneity of traditional tumor biopsy …
pancreatic cancer. Scand J Surg, … of invasion and heterogeneity of traditional tumor biopsy …
长链非编码RNA 在神经退行性疾病中的重要作用
W Xiong, L Lu, J Li - 中国神经再生研究(英文版), 2024 - sjzsyj.com.cn
… Owing to their heterogeneous genomic location relative to the protein-coding position, …
Although numerous genetic mutations can result in abnormal transcriptional phenotypes in NDs, …
Although numerous genetic mutations can result in abnormal transcriptional phenotypes in NDs, …
人源性卵巢癌异体移植模型的研究进展.
吴建发， 易晓芳 - Journal of International Obstetrics & …, 2016 - search.ebscohost.com
… primary tumor and keep the heterogeneity of primary tumor. … 大鼠肉瘤致死性癌基因同源物
(KRAS),磷脂酰肌醇3 激酶催化亚… Circulating and disseminated tumor cells from breast cancer …
(KRAS),磷脂酰肌醇3 激酶催化亚… Circulating and disseminated tumor cells from breast cancer …